Stereotactic ablative radiotherapy for primary renal cell carcinoma

Stereotactic ablative radiotherapy (SAbR) is an emerging non-invasive definitive treatment option for primary renal cell carcinoma (RCC), particularly when surgery is not ideal. Employing ablative doses, SAbR delivered in one to five fractions to the primary tumor has been shown to achieve high loca...

Full description

Bibliographic Details
Main Authors: Daniel X. Yang, Young Suk Kwon, Robert Timmerman, Raquibul Hannan
Format: Article
Language:English
Published: Elsevier 2024-01-01
Series:Clinical and Translational Radiation Oncology
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2405630823001301